Revolution Medicines (NASDAQ:RVMD) Earns “Buy” Rating from Needham & Company LLC
Revolution Medicines (NASDAQ:RVMD – Get Free Report)‘s stock had its “buy” rating reiterated by equities research analysts at Needham & Company LLC in a report issued on Tuesday,Benzinga reports. They presently have a $57.00 target price on the stock. Needham & Company LLC’s price target would indicate a potential upside of 48.40% from the company’s […]
Revolution Medicines (NASDAQ:RVMD – Get Free Report)‘s stock had its “buy” rating reiterated by equities research analysts at Needham & Company LLC in a report issued on Tuesday,Benzinga reports. They presently have a $57.00 target price on the stock. Needham & Company LLC’s price target would indicate a potential upside of 48.40% from the company’s […]
